Company Profile
Updated: 05-NOV-09Aghajanian and Company Inc.
Private Company, Headquarters Location
806 Sharon Dr., Ste. 2-C, Cleveland, OH 44145, United States
(440)871-7817, (440)871-7786 fax,
Primary SIC: Specialty Cleaning Polishing, Primary NAICS: Polish and Other Sanitation Good Manufacturing
Description: Manufacturing: Specialty Cleaning Polishing
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Award-Winning EZ Brite Brands, Inc., 'Zero-Waste' Manufacturer, to Host Bioneers Cleveland Tour for 2nd Consecutive Year.
PR Newswire; 11/2/2009; 797 words; ...EZ Brite Brands, Inc., an award-winning, "zero-waste" company that develops and manufactures...plant tour," says Ed Aghajanian, president, EZ Brite Brands, Inc. "We're always...operated this way," Aghajanian adds. "Our products...
CARPOD(R) Delivers Cargo-Carrying Solutions in Time for Summer.
PR Newswire; 6/8/2009; 800 words; ...carpodrack.com/. About Carpod Inc. Founded in 2007, Carpod Inc. is the innovative company behind CARPOD(R), the carrier...and magazines. Contact: Martin Aghajanian CEO/President, Carpod Inc. 818-395-8676 martin@carpodrack...
2009 Evolution of Manufacturing: 'Briter' days ahead
Smart Business Cleveland; 2/1/2009; 568 words; ...reading this story, Ed Aghajanian would probably like to...At EZ Brite Brands Inc., the Westlake manufacturer...safe materials, but the company has put the same expectation...tight economic times, Aghajanian has repeatedly asked...REACH: EZ Brite Brands Inc., (440) 871-7817...
BiPar Sciences Expands Clinical Development of BSI-201, A Novel PARP Inhibitor, With Phase 2 Trial in Uterine Cancer.
PR Newswire; 5/28/2008; 859 words; ...BiPar Sciences, Inc. today announced it has...PARP) inhibitor in the company's DNA repair portfolio...tolerated," said Carol Aghajanian, M.D., chief of the...Development of BiPar Sciences, Inc., +1-650-635...for BiPar Sciences, Inc. Web site: http...
BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer.
Health & Medicine Week; 5/19/2008; 752 words; BiPar Sciences, Inc. announced the expansion...a>). The company is evaluating BSI-201...ovarian cancer, said Carol Aghajanian, M.D., co- principal...sensitive to the drug. The company is currently conducting...Health, BiPar Sciences Inc. This article was prepared...
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning